Ex vivo analysis of spike-specific CD8+ T cells by peptide MHC (pMHC) tetramers was performed in a subset of postvaccination participants from the HCs and each MS cohort (Supplemental Table 2). This evidence concerns the gene CD8A and myeloid sarcoma.